2 results
Not approvedWill not start
The primary objective of this study is to demonstrate that the IOP-lowering efficacy of Travoprost Ophthalmic Solution, 0.004% (preserved with POLYQUAD) is noninferior to Timolol Ophthalmic Solution (0.5% or 0.25%) in pediatric glaucoma patients.
Approved WMOWill not start
Primary Objective: To study feasibility of a novel Splendor-X SMART system platform for hair removal treatment for all skin types. Secondary Objectives: To study efficacy and safety of the Splendor-X SMART system for hair removal treatment for all…